Our Pricing

Buy Mounjaro Single Pen UK Online — From £135.00 with Free Consultation

When you buy Mounjaro single pen UK online from Cured Pharmacy, you receive genuine UK-licensed tirzepatide injections from £135.00, dispensed by our GPhC-registered team following a free clinical assessment. Every Mounjaro KwikPen is MHRA-approved, delivered discreetly to your door, and prescribed only after a UK prescriber reviews your suitability.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for chronic weight management [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, regulating appetite, slowing gastric emptying, and improving insulin sensitivity.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly higher than comparator treatments [1]. Clinical data demonstrates that tirzepatide's dual-agonist mechanism produces greater weight loss outcomes than GLP-1 monotherapy in head-to-head studies [2].

Each Mounjaro KwikPen delivers a single pre-measured dose administered subcutaneously once weekly. The treatment follows a gradual dose escalation schedule starting at 2.5mg, allowing your body to adjust whilst minimising gastrointestinal side effects commonly associated with GLP-1 therapies.

Mounjaro Single Pen Dosing and Treatment Schedule

Your UK prescriber will initiate treatment at 2.5mg once weekly for the first four weeks. This starter dose allows your digestive system to adapt to tirzepatide's mechanism whilst establishing baseline tolerability. After the initial month, your dose typically increases to 5mg weekly, with further escalations every four weeks until reaching your optimal maintenance dose [3].

Available maintenance doses include 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, depending on your weight loss progress and side effect profile. Most patients achieve best results on higher maintenance doses, though your prescriber will personalise the schedule based on your clinical response and tolerability markers.

Administering Your Mounjaro Injection

Each KwikPen contains a single dose with a hidden needle that automatically retracts after injection. Administer into the abdomen, thigh, or upper arm on the same day each week, rotating injection sites to prevent lipodystrophy. The entire process takes under 10 seconds, and our clinical team provides step-by-step video guidance with every order.

Mounjaro vs Wegovy: Comparing UK Weight Loss Injections

Both Mounjaro and Wegovy are MHRA-licensed injectable treatments for chronic weight management, but they operate through distinct pharmacological pathways. Wegovy contains semaglutide, a selective GLP-1 receptor agonist, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 receptors simultaneously.

In comparative analyses, tirzepatide demonstrated superior weight reduction outcomes. The SURMOUNT-1 trial showed 22.5% average weight loss at the highest dose, compared to 14.9% with semaglutide 2.4mg in the STEP-1 trial [1][4]. However, individual response varies, and some patients achieve excellent results with either medication subject to prescriber assessment.

Pricing differs significantly between the two treatments. Wegovy starts from lower entry prices, making it accessible for patients with tighter budgets, whilst Mounjaro's pricing reflects its newer dual-agonist formulation and higher efficacy data. Your UK prescriber will discuss both options during your free consultation, considering your medical history, weight loss goals, and budget constraints.

Which Treatment Is Right for You?

Patients with higher baseline BMI or those who haven't achieved adequate results with single-pathway GLP-1 treatments may benefit more from Mounjaro's dual-receptor mechanism. Conversely, individuals seeking a cost-effective starting point often begin with Wegovy. Both require identical weekly injection schedules and carry similar gastrointestinal side effect profiles, though some patients tolerate one formulation better than the other.

Who Can Use Mounjaro in the UK?

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [3]. Your UK prescriber will calculate your BMI and review your medical history during the online consultation to confirm eligibility.

Certain conditions preclude Mounjaro use. You cannot receive a prescription if you have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, diabetic retinopathy complications, or if you're pregnant, breastfeeding, or planning pregnancy within the treatment period [5].

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription dispensed from Cured Pharmacy, ensuring all clinical assessments meet MHRA and GPhC standards. If Mounjaro isn't suitable for you, our prescribers will discuss alternative weight management options including Wegovy, Saxenda, or oral treatments like Orlistat.

Common Side Effects and How to Manage Them

The most frequently reported side effects are gastrointestinal: nausea affects approximately 20-30% of patients, particularly during dose escalation phases [1]. Diarrhoea, constipation, vomiting, and abdominal discomfort also occur commonly but typically diminish after 4-8 weeks as your body adapts to the medication.

To minimise nausea, eat smaller, more frequent meals rather than large portions, avoid high-fat foods that slow digestion further, and stay well-hydrated throughout the day. Taking your injection in the evening rather than morning may also reduce daytime nausea for some patients. If side effects remain intolerable, your prescriber can slow the dose escalation schedule or adjust your maintenance dose.

Rare but serious adverse effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder disease, acute kidney injury, and hypoglycaemia when combined with insulin or sulfonylureas [5]. Contact your GP or NHS 111 immediately if you experience persistent severe abdominal pain, visual changes, or signs of allergic reaction. Our clinical team remains available via phone on (+44) 116 4646009 for any medication-related concerns.

When to Contact Your Prescriber

Seek medical advice if you experience severe or persistent vomiting preventing adequate fluid intake, signs of dehydration (dark urine, dizziness, reduced urination), unexplained severe abdominal pain, or changes in vision. These symptoms may indicate complications requiring immediate clinical assessment and potential treatment modification.

How to Order Mounjaro from Cured Pharmacy

Start by completing our free online consultation, which takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber reviews your assessment within hours (typically same-day on weekdays), and if clinically appropriate, issues a prescription for your starting dose.

Once approved, our GPhC-registered pharmacy team dispenses your Mounjaro KwikPen in discreet, unbranded packaging with no external pharmacy markings. We offer next-day delivery across the UK via tracked courier, with temperature-controlled packaging to maintain the medication's stability during transit. All orders include comprehensive patient information leaflets, injection guides, and sharps disposal instructions.

Ongoing prescriptions require brief follow-up consultations every 8-12 weeks to monitor your progress, adjust dosing as needed, and ensure continued safety. Our clinical team tracks your weight loss trajectory and can modify your treatment plan based on your results. Transparent pricing means you see the exact cost before your consultation — no hidden fees or surprise charges at checkout.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14617
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro (tirzepatide): Risk of thyroid C-cell tumours and other safety information. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment alongside diet and exercise modifications.